{"id":"W4214747639","doi":"10.1016/s2152-2650(21)01485-3","title":"Poster: HL-147: Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Stage (stratigraphy); Medicine; Oncology; Internal medicine; Hodgkin lymphoma; Chemotherapy; Lymphoma; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003687453,0.0003704006,0.001232275,0.0004359336,0.0002577117,0.001141671,0.0005530443,0.000984157,0.00372417],"category_scores_gemma":[0.00279115,0.0002159509,0.00123563,0.0006221525,0.0003025944,0.0009396049,0.000447872,0.001655005,0.0005723138],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007806847,"about_ca_system_score_gemma":0.001022901,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007094763,"about_ca_topic_score_gemma":0.002771932,"domain_scores_codex":[0.9991664,0.0004266838,0.0001006774,0.00007215031,0.000156626,0.00007748442],"domain_scores_gemma":[0.9980872,0.0008834583,0.0004689824,0.0000659928,0.000183917,0.0003102659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.08484022,0.002447702,0.06569528,0.00530812,0.005224549,0.0003666144,0.0002603781,0.001363852,0.004312461,0.0008025327,0.04703092,0.7823473],"study_design_scores_gemma":[0.0892205,0.07907323,0.5594245,0.004642637,0.01405048,0.002199761,0.0004308038,0.002016153,0.004215468,0.001316566,0.2432211,0.0001888347],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.5780354,0.3722037,0.001164041,0.01435862,0.003648595,0.0009026054,0.005112282,0.0001643614,0.02441042],"genre_scores_gemma":[0.8236702,0.1369217,0.002361723,0.01911735,0.003413183,0.0005223329,0.007401604,0.00008706752,0.006504883],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.00372417,"threshold_uncertainty_score":0.01950139,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01525284509391409,"score_gpt":0.287328684901338,"score_spread":0.2720758398074239,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}